IL4 and glioblastoma: The immunotoxins' utility and specificity are dictated by the targeted tumor antigen, and in recent years, many targets have been explored for GBM, mainly focused on the receptor for transferrin, transforming growth factor alpha (TGF-α), IL-13, IL-4, and EGFRvIII.